97108 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses; Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus Herpes simplex virus
VACCINE COMPRISING AN ANTIBODY OR AN FC-CONTAINING FUSION PROTEIN COMPRISING AN FC PART OF AN ANTIBODY
#2HERPES SIMPLEX VIRUS TYPES 1 AND 2 LATERAL FLOW ASSAY
#3CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING gD AND ONCOLYTIC VIRUSES FOR CANCER THERAPY AND TREATMENT OF HSV
#4COMPOSITIONS AND METHODS FOR PREVENTING OR AMELIORATING NEONATAL HSV INFECTION
#5OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE
#6COMPOSITIONS AND METHODS FOR THE TREATMENT OF HERPES SIMPLEX VIRUS INFECTION
#7COMPOSITIONS AND METHODS FOR TARGETING CD99-EXPRESSING CANCERS
#8TREATMENT OF HERPES SIMPLEX VIRUS INFECTION
#9SYSTEMS AND METHODS TO LINK CD40 SIGNALING TO ANTIGEN BINDING
#10METHODS AND COMPOSITIONS FOR DEPLETING NATURAL KILLER CELLS AND USES THEREOF IN CELLULAR THERAPIES
#11HSV gE ANTIBODIES
#12ANTI-GLYCOPROTEIN D ANTIBODIES, METHODS OF PREPARATION, AND USES THEREOF
#13SYSTEMS AND METHODS TO PRODUCE B CELLS GENETICALLY MODIFIED TO EXPRESS SELECTED ANTIBODIES
#14ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#15USE OF ANTIBODY DRUG CONJUGATES COMPRISING TUBULIN DISRUPTING AGENTS TO TREAT SOLID TUMOR
#16Optimized crosslinkers for trapping a target on a substrate
#17TOPICAL APPLICATION FOR AN ANTI-HSV ANTIBODY
#18MONOCLONAL ANTIBODIES FOR PREVENTION AND TREATMENT OF HERPES SIMPLEX VIRAL INFECTIONS
#19Monoclonal antibody 11B2C7 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2
#20Monoclonal antibody 14F5F6 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2
#21COMPOSITIONS AND METHODS FOR PREVENTING OR AMELIORATING NEONATAL HSV INFECTION
#22COMPOSITIONS AND METHODS FOR ANTIBODY DELIVERY
#23TETZ-PROTEINS AND PRION-LIKE PROTEINS AND ASSOCIATED METHODS
#24Chimeric antigen receptor and CAR-T cells that bind a herpes virus antigen
#25Systems and methods to produce B cells genetically modified to express selected antibodies
#26TARGETING MOIETY-DECORATED ONCOLYTIC VIRUSES
#27HERPES 1 ANTIBODY SYSTEM
#28Compositions and methods for inhibiting pathogen infection
#29Recombinant herpes simplex virus having expression cassette expressing fused protein of cancer cell-targeting domain and extracellular domain of HVEM and use thereof
#30OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE
#31Compositions and methods for targeting CD99-expressing cancers
#32CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS (HSV) RELATED KERATITIS
#33BINDING MOLECULES TARGETING PATHOGENS
#34Anti-HSV GB monoclonal antibody or antigen-binding fragment thereof
#35Passive antibody dependent cell-mediated activation
#36Use of Antibody Drug Conjugates Comprising Tubulin Disrupting Agents to Treat Solid Tumor
#37Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides
#38Anti-HSV synergistic activity of antibodies and antiviral agents
#39METHODS OF DETECTING APOBEC3 EXPRESSION AND PREDICTING CLINICAL OUTCOMES
#40PINBALL HERPES ANTIBODY SYSTEM
#41Compositions and methods for inhibiting pathogen infection
#42VARIANT ANTIBODIES FOR SITE-SPECIFIC CONJUGATION
#43Antimicrobial compositions comprising single domain antibodies and exotoxin
#44Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response
#45Optimized crosslinkers for trapping a target on a substrate
#46BINDING MOLECULES TARGETING PATHOGENS
#47Human monoclonal antibodies endowed with strong neutralizing activity against HSV-1 and HSV-2
#48Topical application for an anti-HSV antibody
#49Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxin
#50EPITOPES OF HERPES SIMPLEX VIRUS
#51Canine health product containing antibodies against canine parvovirus type 2
#52Compositions and methods for inhibiting pathogen infection
#53Polyclonal bispecific antibody compositions and method of use
#54BINDING MOLECULES TARGETING PATHOGENS
#55Anti-HSV antibody
#56HERPES SIMPLEX VIRUS
#57USE OF CAMELID-DERIVED VARIABLE HEAVY CHAIN VARIABLE REGIONS (VHH) TARGETING HUMAN CD18 AND ICAM-1 AS A MICROBICIDE TO PREVENT HIV-1 TRANSMISSION
#58Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection
#59Anti-HSV antibody
#60Anti-herpes simplex virus antibodies and methods of use thereof
#61Polyclonal bispecific antibody compositions and method of use
#62Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
#63Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases
#64Determination of Interactions of Constant Parts of Antibodies with FC-Gamma Receptors
#65Modified antibodies for passive immunotherapy
#66Engineered scFv against bovine herpes virus type I
#67Anti-herpes simplex virus antibodies and methods of use thereof
#68Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules
#69COMPOSITIONS AND METHODS FOR TREATING HERPES SIMPLEX VIRUS INFECTIONS AND RELATED DISEASES
#70METHODS AND COMPOSITIONS FOR TREATING HERPES INFECTIONS
#71Humanized immunoglobulins
#72Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
#73Equine herpesvirus vaccine
#74Plant production of immunoglobulins with reduced fucosylation
#75Specificity exchangers that redirect antibodies to a pathogen
#76Methods and compositions for treating herpes infections
#77Specificity exchangers that redirect antibodies to a pathogen
#78ASSAY FOR SCREENING FOR AN ANTI-VIRAL AGENT
#79Equine herpesvirus vaccine
#80Methods and compositions for treating herpes infections